The global market for Throat Lozenges is estimated at US$5.7 Billion in 2023 and is projected to reach US$7.9 Billion by 2030, growing at a CAGR of 4.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the throat lozenges market is driven by several factors, including the increasing prevalence of respiratory infections and the rising awareness of throat health. Seasonal changes and the global spread of flu and cold viruses have heightened the demand for effective symptomatic relief, boosting lozenge sales. Technological advancements in lozenge manufacturing have resulted in products with enhanced efficacy and faster onset of action. Additionally, the trend towards self-medication and the preference for over-the-counter remedies contribute significantly to market expansion. The growing elderly population, who are more prone to respiratory ailments, is another key driver. Marketing strategies emphasizing natural ingredients and health benefits are resonating well with consumers, further propelling market growth. Lastly, the expansion of distribution channels, particularly in emerging markets, is facilitating wider access to throat lozenges, supporting sustained market growth.
The growth in the throat lozenges market is driven by several factors, including the increasing prevalence of respiratory infections and the rising awareness of throat health. Seasonal changes and the global spread of flu and cold viruses have heightened the demand for effective symptomatic relief, boosting lozenge sales. Technological advancements in lozenge manufacturing have resulted in products with enhanced efficacy and faster onset of action. Additionally, the trend towards self-medication and the preference for over-the-counter remedies contribute significantly to market expansion. The growing elderly population, who are more prone to respiratory ailments, is another key driver. Marketing strategies emphasizing natural ingredients and health benefits are resonating well with consumers, further propelling market growth. Lastly, the expansion of distribution channels, particularly in emerging markets, is facilitating wider access to throat lozenges, supporting sustained market growth.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Hard Candy segment, which is expected to reach US$4.9 Billion by 2030 with a CAGR of a 5.2%. The Soft Lozenges segment is also set to grow at 4.1% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $1.4 Billion in 2023, and China, forecasted to grow at an impressive 6.5% CAGR to reach $1.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Throat Lozenges Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Throat Lozenges Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Throat Lozenges Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Bayer AG, Cipla Ltd., Church & Dwight Co., Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 87 Featured):
- Bayer AG
- Cipla Ltd.
- Church & Dwight Co., Inc.
- Blackmores Limited
- Amrutanjan Health Care Ltd.
- Anabolic Laboratories LLC
- Eclipse Pharmacy Solutions Inc.
- Beenz Limited
- Apex Drug House
- Boiron USA
- Blooms The Chemist Management Services Limited
- DC Nutrition Group Inc.
- Bionorica SE
- Beekeeper`s Naturals Inc.
- Clyor Inc.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned
- Bayer AG
- Cipla Ltd.
- Church & Dwight Co., Inc.
- Blackmores Limited
- Amrutanjan Health Care Ltd.
- Anabolic Laboratories LLC
- Eclipse Pharmacy Solutions Inc.
- Beenz Limited
- Apex Drug House
- Boiron USA
- Blooms The Chemist Management Services Limited
- DC Nutrition Group Inc.
- Bionorica SE
- Beekeeper`s Naturals Inc.
- Clyor Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 407 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 5.7 Billion |
| Forecasted Market Value ( USD | $ 7.9 Billion |
| Compound Annual Growth Rate | 4.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
